0001144204-18-035852.txt : 20180626
0001144204-18-035852.hdr.sgml : 20180626
20180626165442
ACCESSION NUMBER: 0001144204-18-035852
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180625
FILED AS OF DATE: 20180626
DATE AS OF CHANGE: 20180626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chiesi Ventures, Inc.
CENTRAL INDEX KEY: 0001744577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38542
FILM NUMBER: 18919803
BUSINESS ADDRESS:
STREET 1: P.O. BOX 110287
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 110287
BUSINESS PHONE: 919-998-3300
MAIL ADDRESS:
STREET 1: P.O. BOX 110287
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 110287
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chiesi Ventures, LP
CENTRAL INDEX KEY: 0001744641
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38542
FILM NUMBER: 18919804
BUSINESS ADDRESS:
STREET 1: P.O. BOX 110287
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 110287
BUSINESS PHONE: 919-998-3300
MAIL ADDRESS:
STREET 1: P.O. BOX 110287
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 110287
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chiesi Giacomo
CENTRAL INDEX KEY: 0001744492
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38542
FILM NUMBER: 18919805
MAIL ADDRESS:
STREET 1: P.O. BOX 110287
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 110287
FORMER NAME:
FORMER CONFORMED NAME: Chiesi Giancomo
DATE OF NAME CHANGE: 20180622
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kezar Life Sciences, Inc.
CENTRAL INDEX KEY: 0001645666
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473366145
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-822-5600
MAIL ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
tv497342_form4.xml
FORM 4
X0306
4
2018-06-25
1
0001645666
Kezar Life Sciences, Inc.
KZR
0001744577
Chiesi Ventures, Inc.
P.O. BOX 110287
RESEARCH TRIANGLE PARK
NC
27709
0
0
1
0
0001744641
Chiesi Ventures, LP
P.O. BOX 110287
RESEARCH TRIANGLE PARK
NC
27709
0
0
1
0
0001744492
Chiesi Giacomo
P.O. BOX 110287
RESEARCH TRIANGLE PARK
NC
27709
0
0
1
0
Common Stock, par value $0.001 per share
2018-06-25
4
C
0
314819
A
314819
I
See footnote
Series B Preferred Stock, par value $0.001 per share
2018-06-25
4
C
0
314819
0
A
Common Stock
314819
0
I
See footnote
The Series B Preferred Stock, par value $0.001 per share, converted into Common Stock, par value $0.001 per share, on a one-for-one basis and had no expiration date.
These shares are held of record by Chiesi Ventures, LP ("Chiesi Ventures"). Chiesi Ventures, Inc. ("Chiesi") is the general partner of Chiesi Ventures, and Mr. Giacomo Chiesi is President of, and may be deemed to have control of, Chiesi. By virtue of their respectively relationships with Chiesi Ventures, each of Chiesi and Mr. Chiesi may be deemed to indirectly beneficially own the shares of which Chiesi Ventures is the record owner. Each of Chiesi and Mr. Chiesi disclaims beneficial ownership of the shares reported herein, except to the extent of its or his respective pecuniary interests therein. This report shall not be deemed an admission that such reporting persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.
/s/ Amanda Keister, attorney-in-fact for Chiesi Ventures, LP
2018-06-26
/s/ Amanda Keister, attorney-in-fact for Chiesi Ventures, Inc.
2018-06-26
/s/ Amanda Keister, attorney-in-fact for Giacomo Chiesi
2018-06-26